{"cluster": 20, "subcluster": 15, "abstract_summ": "In this note, we compare several well-established group testing schemes in the context of qPCR testing for COVID-19.Currently proposed COVID-19 group testing schemes offer a gain up to 10X scale-up.Currently proposed COVID-19 group testing schemes offer a gain up to 15X-20X scale-up.This note is intended as a helpful handbook for labs implementing group testing methods.We compare outcomes that may be expected in different testing situations and provide general recommendations for group testing implementation.", "title_summ": "Increasing testing throughput and case detection with a pooled-sample Bayesian approach in the context of COVID-19The usefulness of SARS-CoV-2 test positive proportion as a surveillance toolGroup Testing Performance Evaluation for SARS-CoV-2 Massive Scale Screening and TestingGroup testing for SARS-CoV-2 allows for up to 10-fold efficiency increase across realistic scenarios and testing strategiesEvaluation of Group Testing for SARS-CoV-2 RNAEvaluation of Pool-based Testing Approaches to Enable Population-wide Screening for COVID-19On Accelerated Testing for COVID-19 Using Group TestingAccelerated infection testing at scale: a proposal for inference with single test on multiple patientsA comparison of group testing architectures for COVID-19 testingBoosting test-efficiency by pooled testing strategies for SARS-CoV-2Optimal Covid-19 Pool Testing with a priori InformationOptimization of group size in pool testing strategy for SARS\u2010CoV\u20102: A simple mathematical modelGroup testing performance evaluation for SARS-CoV-2 massive scale screening and testingGroup Testing for Sars-Cov-2 to Enable Rapid Scale-Up of Testing and Real-Time Surveillance of Incidence", "title_abstract_phrases": "Evaluation of Group Testing for SARS-CoV-2 RNADuring the current COVID-19 pandemic, testing kit and RNA extraction kit availability has become a major limiting factor in the ability to determine patient disease status and accurately quantify prevalence.The model can be adapted to specific prevalences, generating a tailored to the context implementation of the pool testing strategy.A Bayesian inference analysis in which hierarchical testing stages can have different sensitivities is implemented and benchmarked against early COVID-19 testing data.However, the lack of adequate testing kits could be a bottleneck, especially in the case of unanticipated new diseases, such as COVID-19, where the testing technology, manufacturing capability, distribution, human skills and laboratories might be unavailable or in short supply.Even for moderate losses in test sensitivity upon pooling, substantial increases in testing throughput and detection efficiency are predicted, suggesting that sample pooling is a viable avenue to circumvent current testing bottlenecks for COVID-19.The usefulness of SARS-CoV-2 test positive proportion as a surveillance toolComparison of COVID-19 case numbers over time and between locations is complicated by limits to virologic testing confirm SARS-CoV-2 infection, leading to under-reporting of incidence, and by variations in testing capacity between locations and over time."}